1. Amyloid Precursor Protein (APP) Translation Inhibitors for Anti-Amyloid Efficacy in Down Syndrome and Familial Alzheimer’s Disease. This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.